John R Moore's Net Worth

$2.92 Million

Estimate Recalculated Nov 1, 2024 02:23PM EST

Who is John R Moore

John R Moore has an estimated net worth of $2.92 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Edgewise Therapeutics, Inc., and ARRAY BIOPHARMA INC.

SEC CIK

John R Moore's CIK is 0001191702

Past Insider Trading and Trends

2022 was John R Moore's most active year for acquiring shares with 25 total transactions. John R Moore's most active month to acquire stocks was the month of May. 2022 was John R Moore's most active year for disposing of shares, totalling 44 transactions. John R Moore's most active month to dispose stocks was the month of May. 2015 saw John R Moore paying a total of $182,331.76 for 218,681 shares, this is the most they've acquired in one year. In 2024 John R Moore cashed out on 66,834 shares for a total of $633,793.42, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nivalis Therapeutics, Inc.

Investor
Updated Sep 14, 2016
Form 4
12.30K
Sep 14, 2016
12.30K
Grant
Sep 12
Form 4
7.65K
Sep 15, 2015
7.65K
Grant
Sep 11
Form 3
Jun 16, 2015
2.16K
Showing 3 results

Edgewise Therapeutics, Inc.

General Counsel
Updated Aug 14, 2024
Form 4
161.88K
Aug 14, 2024
161.88K
Grant
Aug 12
Form 4
-18.78%
-1.96K
$18.91
-$36.99K
May 03, 2024
8.46K
Sale
May 01 - May 02
Form 4
-24.26%
-29.84K
$10.97
-$539.22K
Feb 09, 2024
93.16K
Sale
Feb 07 - Feb 09
Form 4
-100.00%
-8.50K
$10.50
-$89.22K
Dec 28, 2023
Sale
Dec 27
Form 4
200.00K
Aug 18, 2023
200.00K
Grant
Aug 17
Form 4
-10.05%
-1.90K
$8.90
-$16.89K
May 03, 2023
16.98K
Sale
May 01 - May 02
Form 4
-3.62%
-4.73K
$5.85
-$37.03K
Oct 05, 2022
126.00K
Sale
ScheduledOct 03
Form 4
-3.49%
-4.73K
$6.42
-$42.47K
Sep 08, 2022
130.73K
Sale
ScheduledSep 06
Form 4
200.00K
Aug 10, 2022
200.00K
Grant
Aug 08
Form 4
-3.59%
-9.23K
$5.33
-$73.60K
Aug 05, 2022
248.02K
Sale
ScheduledAug 03
Form 4
-3.46%
-9.23K
$4.85
-$64.93K
Jul 07, 2022
257.25K
Sale
ScheduledJul 05 - Jul 06
Form 4
-20.31%
-67.93K
$4.26
-$349.32K
Jun 21, 2022
266.48K
Sale
ScheduledJun 16 - Jun 21
Form 4
-7.31%
-26.38K
$3.41
-$141.01K
Jun 15, 2022
334.41K
Sale
ScheduledJun 13 - Jun 15
Form 4
-14.28%
-27.31K
$3.58
-$156.49K
Jun 10, 2022
163.87K
Sale
ScheduledJun 08 - Jun 10
Form 4
-10.86%
-47.29K
$3.88
-$225.64K
Jun 07, 2022
388.09K
Sale
ScheduledJun 03 - Jun 07
Form 4
-78.26%
-10.80K
$7.42
-$80.15K
May 18, 2022
3.00K
Sale
ScheduledMay 16
Form 4
15.63K
May 03, 2022
15.63K
Grant
May 01
Form 4
$0.71
$3.83K
Jan 25, 2022
217.68K
Options
Jan 21
Form 4
$0.71
$3.83K
Dec 30, 2021
217.68K
Options
Dec 28
Form 4
120.00K
Aug 19, 2021
120.00K
Grant
Aug 17
Form 3
Mar 25, 2021
Showing 21 results

ARRAY BIOPHARMA INC

VP, General Counsel
Updated Apr 06, 2017
Form 4/A
-13.71%
-6.37K
$8.94
-$56.95K
Apr 06, 2017
40.10K
Tax
Apr 01
Form 4
-6.62%
-4.41K
$8.94
-$39.41K
Apr 04, 2017
62.22K
Options
Apr 01
Form 4
153.13K
Dec 29, 2016
153.13K
Grant
Dec 27
Form 4
439.24%
185.62K
$3.00
-$7.51K
Apr 05, 2016
227.88K
Grant
Apr 01
Form 4
1,222.86%
188.13K
Apr 03, 2015
203.51K
Grant
Apr 01
Form 4/A
Mar 24, 2015
15.38K
Form 4
-16.46%
-7.54K
$7.96
$122.30K
Mar 04, 2015
38.27K
Options
Mar 01
Form 4
45.81K
Aug 20, 2014
45.81K
Grant
Aug 18
Form 4
125.00K
Apr 03, 2014
125.00K
Grant
Apr 01
Form 4
-99.83%
-11.67K
$5.79
-$67.55K
Dec 03, 2013
20.00
Sale
ScheduledNov 29
Form 4
-1.68%
-200.00
$5.79
-$1.16K
Nov 15, 2013
11.69K
Sale
ScheduledNov 13
Form 4
-54.18%
-75.38K
$5.00
-$318.40K
Aug 02, 2013
63.76K
Sale
ScheduledAug 01 - Aug 02
Form 4
-10.72%
-5.00K
$4.87
-$953.75
Jul 25, 2013
41.65K
Sale
ScheduledJul 23 - Jul 25
Form 4
-32.32%
-20.00K
$4.63
-$75.60K
Apr 24, 2013
41.89K
Options
ScheduledApr 23
Form 4
80.00K
Apr 01, 2013
80.00K
Grant
Mar 28
Form 4
-70.60%
-28.55K
$5.69
-$162.31K
Oct 09, 2012
11.89K
Sale
ScheduledOct 08
Form 4
45.38%
11.89K
Oct 05, 2012
40.43K
Grant
Oct 04
Form 4
75.00K
Apr 03, 2012
75.00K
Grant
Mar 30
Form 4
28.55K
Oct 04, 2011
28.55K
Grant
Oct 04
Form 4
61.25K
Apr 05, 2011
61.25K
Grant
Mar 31
Form 4
-100.00%
-356.00
$3.30
-$1.17K
Apr 05, 2011
Sale
ScheduledApr 05
Form 4
-89.26%
-2.96K
$3.30
-$9.76K
Jan 12, 2011
356.00
Sale
ScheduledJan 10 - Jan 11
Form 4
-100.00%
-24.04K
$3.25
-$78.13K
Jan 06, 2011
3.32K
Sale
ScheduledJan 06
Form 4
28.32%
6.04K
$3.29
-$66.02K
Oct 06, 2010
27.35K
Grant
ScheduledOct 04 - Oct 05
Form 4
-23.95%
-6.32K
$3.25
-$20.54K
Aug 04, 2010
21.32K
Sale
ScheduledAug 02 - Aug 03
Form 4
51.05K
Apr 01, 2010
51.05K
Grant
Mar 31
Form 4
337.35%
21.32K
Oct 06, 2009
27.64K
Grant
Oct 05
Form 4
37.50K
May 01, 2009
37.50K
Grant
Apr 29
Form 4
37.50K
Sep 11, 2008
37.50K
Grant
Sep 09
Form 4
-73.14%
-27.26K
$9.21
-$221.70K
Nov 20, 2006
10.01K
Sale
Nov 20
Form 4
20.00K
Sep 14, 2006
20.00K
Grant
Sep 13
Form 4
-66.43%
-4.46K
$9.38
-$41.80K
Feb 22, 2006
2.25K
Sale
Feb 17
Form 4
60.00K
Aug 08, 2005
60.00K
Grant
Aug 04
Form 4
10.50K
Aug 03, 2004
10.50K
Grant
Jul 30
Form 4
24.37K
Aug 04, 2003
24.37K
Grant
Jul 01 - Aug 01
Showing 35 results